HEAL

Restart Life Sciences Stock Price

Symbol: CNSX:HEALMarket Cap: CA$3.4mCategory: Pharmaceuticals & Biotech

HEAL Share Price Performance

HEAL Community Fair Values

    Recent HEAL News & Updates

    No updates

    Restart Life Sciences Corp. Key Details

    CA$0

    Revenue

    CA$0

    Cost of Revenue

    CA$0

    Gross Profit

    CA$449.6k

    Other Expenses

    -CA$449.6k

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.013
    Gross Margin
    0%
    Net Profit Margin
    0%
    Debt/Equity Ratio
    0%

    Restart Life Sciences Corp. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About HEAL

    Founded
    2004
    Employees
    n/a
    CEO
    Steve Loutskou
    WebsiteView website
    www.restartlife.co

    Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.

    Canadian Market Performance

    • 7 Days: 0.9%
    • 3 Months: 11.0%
    • 1 Year: 18.4%
    • Year to Date: 10.4%
    The market has been flat in the last week, however the Industrials sector is down 3.1%. More promisingly, the market is up 18% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
    The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
    Continue reading